These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6299867)

  • 21. Induction of murine teratocarcinoma cell differentiation by suppression of poly(ADP-ribose) synthesis.
    Ohashi Y; Ueda K; Hayaishi O; Ikai K; Niwa O
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7132-6. PubMed ID: 6095269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of poly(ADP-ribose) synthetase enhance the cytotoxicity of 42 degrees C and 45 degrees C hyperthermia in cultured Chinese hamster cells.
    Nagle WA; Moss AJ
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Nov; 44(5):475-81. PubMed ID: 6315616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
    Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
    Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADP-ribosylation of highly purified rat brain mitochondria.
    Masmoudi A; Islam F; Mandel P
    J Neurochem; 1988 Jul; 51(1):188-93. PubMed ID: 2837535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotinamide, a poly (ADP-ribose) synthetase inhibitor, ameliorates B-cell function in partially depancreatized rats.
    Inoue Y; Tanigawa K; Nakamura S; Kato Y; Tamura K; Nakase A
    Diabetes Res Clin Pract; 1993; 22(1):19-27. PubMed ID: 8137712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo.
    Rankin PW; Jacobson EL; Benjamin RC; Moss J; Jacobson MK
    J Biol Chem; 1989 Mar; 264(8):4312-7. PubMed ID: 2538435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
    Bolaffi JL; Nagamatsu S; Harris J; Grodsky GM
    Endocrinology; 1987 May; 120(5):2117-22. PubMed ID: 2952491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration.
    Okamoto H
    Biomed Biochim Acta; 1985; 44(1):15-20. PubMed ID: 2986610
    [No Abstract]   [Full Text] [Related]  

  • 29. Survival and B-cell function of mouse pancreatic islets maintained in culture after concomitant exposure to streptozotocin and nicotinamide.
    Strandell E; Eizirik DL; Sandler S
    Exp Clin Endocrinol; 1989 May; 93(2-3):219-24. PubMed ID: 2528468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.
    Radons J; Heller B; Bürkle A; Hartmann B; Rodriguez ML; Kröncke KD; Burkart V; Kolb H
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1270-7. PubMed ID: 8147870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of inhibitors of poly(ADP-ribose) synthesis. Effects on nucleotide metabolism in cultured cells.
    Hunting DJ; Gowans BJ; Henderson JF
    Mol Pharmacol; 1985 Aug; 28(2):200-6. PubMed ID: 2991739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
    Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear response of pancreatic islets to interleukin-1 beta.
    Fernández-Alvarez J; Tomás C; Casamitjana R; Gomis R
    Mol Cell Endocrinol; 1994 Jul; 103(1-2):49-55. PubMed ID: 7958397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of streptozotocin in vitro on proinsulin biosynthesis, insulin release and ATP content of isolated rat islets of Langerhans.
    Maldonato A; Trueheart PA; Renold AE; Sharp GW
    Diabetologia; 1976 Oct; 12(5):471-81. PubMed ID: 135704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ADP-ribose) synthesis induced by nitric oxide in a mouse beta-cell line.
    Inada C; Yamada K; Takane N; Nonaka K
    Life Sci; 1995; 56(18):1467-74. PubMed ID: 7752811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of HaCat keratinocytes to diabetogenic toxins.
    Harel A; Bloch O; Vardi P; Bloch K
    Biochem Pharmacol; 2002 Jan; 63(2):171-8. PubMed ID: 11841791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic ADP-ribose in insulin secretion from pancreatic beta cells.
    Takasawa S; Nata K; Yonekura H; Okamoto H
    Science; 1993 Jan; 259(5093):370-3. PubMed ID: 8420005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes.
    Sims JL; Sikorski GW; Catino DM; Berger SJ; Berger NA
    Biochemistry; 1982 Apr; 21(8):1813-21. PubMed ID: 6282320
    [No Abstract]   [Full Text] [Related]  

  • 40. K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin.
    Kullin M; Li Z; Hansen JB; Björk E; Sandler S; Karlsson FA
    Diabetes; 2000 Jul; 49(7):1131-6. PubMed ID: 10909969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.